Search

Search Results
Results 951 - 960 of 1124 for Diabetes Type II
  • New patent has potential for the treatment of obesity
    News - 11 May 2004
    Two researchers have announced receipt of a patent on the use of MSH analogs--chemicals that regulate fat storage and metabolism in the body.
  • AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement
    News - 28 Apr 2004
    AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border...
  • Sacubitril/Valsartan Alphapharm
    Drug - 7 Jul 2025
    Consumer Medicine Information (CMI) about Sacubitril/Valsartan Alphapharm intended for persons living in Australia.
  • Cozavan
    Drug - 20 Jun 2025
    Consumer Medicine Information (CMI) about Cozavan intended for persons living in Australia.
  • Omtralo
    Drug - 13 Jun 2025
    Consumer Medicine Information (CMI) about Omtralo intended for persons living in Australia.
  • Mersynofen
    Drug - 18 Mar 2025
    Consumer Medicine Information (CMI) about Mersynofen intended for persons living in Australia.
  • Tryzan
    Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Tryzan intended for persons living in Australia.
  • In vitro kidney disease modeling service
    Equipment - 7 Nov 2024
    To perform in vitro kidney disease modeling, a robust model, such as aProximate™, is required.
  • Humalog Vials
    Drug - 14 Oct 2024
    Consumer Medicine Information (CMI) about Humalog Vials intended for persons living in Australia.
  • Humalog U200
    Drug - 14 Oct 2024
    Consumer Medicine Information (CMI) about Humalog U200 intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback